PEPI-TiDP23-C104 is a First in Human Study With a Single Dose Escalation Part and a Multiple Dosing Part for Compounds TMC589337 and TMC589354.
Clinical trial NCT00908414 · WITHDRAWN
Trial details
- NCT number
- NCT00908414
- Sponsor
- Tibotec Pharmaceuticals, Ireland
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-01
- Primary completion
- 2009-10-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.